{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:29Z","timestamp":1791250649382,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.neurol.2014.03.009","type":"journal-article","created":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T03:30:16Z","timestamp":1399087816000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mitochondrial dysfunction affecting visual pathways"],"prefix":"10.1016","volume":"170","author":[{"given":"S.","family":"Leruez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Amati-Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Procaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Milea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2014.03.009_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mcn.2012.08.004","article-title":"The optic nerve: a \u00ab\u00a0mito-window\u00a0\u00bb on mitochondrial neurodegeneration","volume":"55","author":"Maresca","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurol.2014.03.009_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.mito.2013.05.013","article-title":"Optic nerve histopathology in a case of Wolfram Syndrome: a mitochondrial pattern of axonal loss","volume":"13","author":"Ross-Cisneros","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurol.2014.03.009_bib0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tig.2013.05.005","article-title":"Mitochondrial disorders: aetiologies, models systems, and candidate therapies","volume":"29","author":"Farrar","year":"2013","journal-title":"Trends Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajo.2005.03.017","article-title":"Hereditary optic neuropathies: from the mitochondria to the optic nerve","volume":"140","author":"Newman","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neurol.2012.08.005","article-title":"Hereditary optic neuropathies","volume":"168","author":"Milea","year":"2012","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/WNO.0b013e31828d4add","article-title":"Maculopathy and spinocerebellar ataxia type 1: a new association?","volume":"33","author":"Lebranchu","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1442-9071.2010.02212.x","article-title":"Selective wavelength papillometry in Leber hereditary optic neuropathy","volume":"38","author":"Kawasaki","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.visres.2010.07.023","article-title":"Melanopsin-expressing retinal ganglion cells: implications for human diseases","volume":"51","author":"La Morgia","year":"2011","journal-title":"Vision Res"},{"key":"10.1016\/j.neurol.2014.03.009_bib0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bjo.2009.161539","article-title":"Never too old to harbour a young man's disease","volume":"95","author":"Giraudet","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0060","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hbm.20985","article-title":"Evidence for retrochiasmatic tissue loss in Leber's hereditary optic neuropathy","volume":"31","author":"Barcella","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.neurol.2014.03.009_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroimage.2013.05.032","article-title":"Long term cortical plasticity in visual retinotopic areas in humans with silent retinal ganglion cell loss","volume":"81","author":"d\u2019Almeida","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurol.2014.03.009_bib0070","first-page":"465","article-title":"Hereditary optic neuropathies","volume":"1","author":"Newman","year":"2005"},{"key":"10.1016\/j.neurol.2014.03.009_bib0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e318225247b","article-title":"Leber hereditary optic neuropathy mimicking neuromyelitis optica","volume":"31","author":"McClelland","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","article-title":"Dominant optic atrophy mapped to chromosome 3q region II. Clinical and epidemiological aspects","volume":"74","author":"Kjer","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.neurol.2014.03.009_bib0085","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","article-title":"Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates","volume":"120","author":"Yu-Wai-Man","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2014.03.009_bib0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21376","article-title":"Reversible optic neuropathy with OPA1 exon 5b mutation","volume":"63","author":"Cornille","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-3768.2008.01469.x","article-title":"Axonal loss occurs early in dominant optic atrophy","volume":"88","author":"Milea","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0100","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.ophtha.2013.08.008","article-title":"Imaging of the macula indicates early completion of structural deficit in autosomal dominant optic atrophy","volume":"120","author":"R\u00f6nnb\u00e4ck","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2014.03.009_bib0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2350-12-49","article-title":"Genomic deletions in OPA1 associated with dominant optic atrophy in a Danish population","volume":"12","author":"Almind","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/humu.20161","article-title":"eOPA1: an online database for OPA1 mutations","volume":"25","author":"Ferre","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2014.03.009_bib0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/WCO.0b013e3283347b27","article-title":"Genetically determined optic neuropathies","volume":"23","author":"Milea","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0130","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferre","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2014.03.009_bib0135","doi-asserted-by":"crossref","first-page":"e56350","DOI":"10.1371\/journal.pone.0056350","article-title":"Non-image-forming light driven functions are preserved in a mouse model of autosomal dominant optic atrophy","volume":"8","author":"Perganta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2014.03.009_bib0140","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1167\/iovs.12-11137","article-title":"The pupil light reflex in Leber's hereditary optic neuropathy: evidence for preservation of melanopsin-expressing retinal ganglion cells","volume":"54","author":"Moura","year":"2013","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0145","first-page":"675","article-title":"The pupil in dominant optic atrophy","volume":"42","author":"Bremner","year":"2001","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"issue":"Pt. 2","key":"10.1016\/j.neurol.2014.03.009_bib0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u201cplus44 phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0160","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1093\/brain\/aws340","article-title":"Sensorineural hearing loss in OPA1-linked disorders","volume":"136","author":"Leruez","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0165","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0002-9394(03)00665-2","article-title":"The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene","volume":"136","author":"Amati-Bonneau","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ana.20681","article-title":"OPA1 R445H mutation in optic atrophy associated with sensorineural deafness","volume":"58","author":"Amati-Bonneau","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2009.08.083","article-title":"Mutation of OPA1 gene causes deafness by affecting function of auditory nerve terminals","volume":"1300","author":"Huang","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2014.03.009_bib0180","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1136\/jmg.2003.016576","article-title":"OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract","volume":"41","author":"Reynier","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0035-3787(05)85075-1","article-title":"An OPA3 mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs","volume":"161","author":"Verny","year":"2005","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000339310","article-title":"OPA3-related autosomal dominant optic atrophy and cataract with ataxia and areflexia","volume":"68","author":"Ayrignac","year":"2012","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10545-005-0525-8","article-title":"OPA3 mutation screening in patients with unexplained 3-methylglutaconic aciduria","volume":"28","author":"Neas","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2014.03.009_bib0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0205","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurol.2014.03.009_bib0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich's ataxia","volume":"132","author":"Fortuna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1385\/NMM:8:1-2:63","article-title":"Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease","volume":"8","author":"Z\u00fcchner","year":"2006","journal-title":"Neuromol Med"},{"key":"10.1016\/j.neurol.2014.03.009_bib0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jnnp-2013-306387","article-title":"Novel C12orf65 mutations in patients with axonal","volume":"85","author":"Tucci","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2014.03.009_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.neurol.2014.03.009_bib0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2012.180","article-title":"Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype","volume":"15","author":"de Heredia","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.neurol.2014.03.009_bib0235","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1172\/JCI118581","article-title":"A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome","volume":"97","author":"Barrientos","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2014.03.009_bib0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/112067210201200202","article-title":"Ophthalmologic findings in fifteen patients with Wolfram syndrome","volume":"12","author":"Al-Till","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0245","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10038-007-0144-3","article-title":"Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese","volume":"52","author":"Fukuoka","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0250","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004150050223","article-title":"A case of ethambutol-induced optic neuropathy harbouring a primary mitochondrial LHON mutation at nt 11778","volume":"245","author":"Dotti","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0260","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s004150170103","article-title":"Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber hereditary optic neuropathy","volume":"248","author":"De Marinis","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00415-003-0960-0","article-title":"Leber's hereditary optic neuropathy mutations in ethambutol induced optic neuropathy","volume":"250","author":"Hwang","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mito.2009.11.004","article-title":"Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity","volume":"10","author":"Guillet","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurol.2014.03.009_bib0275","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.survophthal.2009.10.005","article-title":"Drug-induced optic neuropathy\u00a0\u2013\u00a0TB or not TB","volume":"55","author":"Pradhan","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.23766","article-title":"Ethambutol toxicity exacerbating the phenotype of CMT2A2","volume":"48","author":"Fonkem","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2014.03.009_bib0285","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archopht.1993.01090110048021","article-title":"Leber's hereditary optic neuropathy masquerading as Tobacco-alcohol amblyopia","volume":"111","author":"Cullom","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0290","first-page":"3175","article-title":"Mutations for Leber hereditary optic neuropathy in patients with alcohol and tobacco optic neuropathy","volume":"17","author":"Amaral-Fernandes","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.neurol.2014.03.009_bib0295","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bjo.83.5.577","article-title":"Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy","volume":"83","author":"Tsao","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0300","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","article-title":"Gene-environment interactions in Leber hereditary optic neuropathy","volume":"132","author":"Kirkman","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0305","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1111\/j.1755-3768.2012.02387.x","article-title":"Leber's optic neuropathy\u00a0\u2013\u00a0visual return on alcohol cessation","volume":"90","author":"Morris","year":"2012","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.neurol.2014.03.009_bib0310","series-title":"Gene Reviews\u2122","article-title":"Mitochondrial DNA- associated Leigh syndrome and NARP","author":"Thorburn","year":"1993"},{"key":"10.1016\/j.neurol.2014.03.009_bib0315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0320","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0925-4439(91)90042-8","article-title":"A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)","volume":"1097","author":"Goto","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurol.2014.03.009_bib0325","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatment for mitochondrial disease-no time to drop our standard","volume":"9","author":"Pfeffer","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0330","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrneurol.2012.167","article-title":"Treatment of optic hereditary neuropathies","volume":"8","author":"Newman","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0335","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/aws279","article-title":"Persistence of the treatment effect of Ibedenone in Leber hereditary optic neuropathy","volume":"136","author":"Klopstock","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","article-title":"Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy","volume":"33","author":"Rudolph","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0350","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0355","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/1756-0500-4-557","article-title":"Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration","volume":"4","author":"Angebault","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.neurol.2014.03.009_bib0360","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2014.03.009_bib0365","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/WNO.0b013e318273c102","article-title":"Visual improvement with the use of ibedenone in the treatment of Wolfram syndrome","volume":"32","author":"Bababeygy","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0375","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotropic expression of human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0380","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archophthalmol.2010.201","article-title":"Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1","volume":"128","author":"Lam","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neurol.2014.03.009_bib0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ejhg.2012.112","article-title":"Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy","volume":"21","author":"Chadderton","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2014.03.009_bib0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/gt.2011.134","article-title":"Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors","volume":"19","author":"Iyer","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.neurol.2014.03.009_bib0395","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature11647","article-title":"Towards germline gene therapy of inherited mitochondrial diseases","volume":"493","author":"Tachibana","year":"2013","journal-title":"Nature"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378714008157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378714008157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T19:55:55Z","timestamp":1597780555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378714008157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0035378714008157"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2014.03.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction affecting visual pathways","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2014.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}